In conclusion, no significant association was found between MYCN gene polymorphisms and Wilms tumor risk in overall analysis, but stratification and haplotype analyses suggested that MYCN gene polymorphisms might be low penetrant variants in Wilms tumor susceptibility. This evidence concerns the gene MYCN and Nephroblastoma.